Single-Cell Heterogeneity of EGFR Pathway Is Linked to Unique Signatures of Drug Response and Malignancy in Patient Derived Glioblastoma Stem Cells.
Masterman-Smith MD, Graham NA, Panosyan EH, Mottahedeh J, Samuels ER, Nunez A, Phillips T, Choe M, Cloughesy TF, Lazareff JA, Liau LM, Yong WH, Graeber TG, Kornblum HI, Lang MF, Li Y, Sun J.
Masterman-Smith MD, et al. Among authors: sun j.
Cancer Res Treat. 2025 Jan 7. doi: 10.4143/crt.2024.859. Online ahead of print.
Cancer Res Treat. 2025.
PMID: 39788641